Resources Contact Us Home
Enterosoluble hard-capsulated medicaments

Image Number 2 for United States Patent #4339463.

The invention provides a novel means for overcoming the problem of undue and irregular delay in the exhibition of the effect of medicine when a patient is administrated with an enterosoluble hard-capsulated medicament. The unexpected discovery that the key parameter ruling the smooth transfer of an enterosoluble capsule from the stomach to the intestinal canals is the overall specific gravity of the capsule has led to the establishment of the invention which proposes an enterosoluble hard-capsulated medicament having an overall specific gravity of at least 1.05 or, preferably, at least 1.10.

  Recently Added Patents
Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirusi in hexameric form
Systems and methods for flow mirroring with network-scoped connection-oriented sink
Automatic population of feature capabilities on a communication device
Compact multi-functional scanning apparatus with retractable flatbed scanner
Apparatus, system, and method for non-interruptively updating firmware on a redundant hardware controller
Electrowetting display devices with a reflective plate structure
Liquid crystal display device
  Randomly Featured Patents
Optical waveguide lateral alignment arrangement
Methods for adaptive video quality enhancement
Snap ring magnetic stopping system for an air driven centrifuge
Generating relational indicators based on analysis of telecommunications events
Methods and associated apparatus for drilling and completing a wellbore junction
Rechargeable non-aqueous thin film lithium battery
Appparatus and method for rigidly stabilizing circuit boards
Face detecting method and photography apparatus using the method
Chronic fatigue syndrome diagnosis
Controlling head heating based on upcoming data sector write pattern